Cargando…
SphK2 over-expression promotes osteosarcoma cell growth
It is needed to explore novel biological markers for early diagnosis and treatment of human osteosarcoma. Sphingosine kinase 2 (SphK2) expression and potential functions in osteosarcoma were studied. We demonstrate that SphK2 is over-expressed in multiple human osteosarcoma tissues and established h...
Autores principales: | Xu, Dawei, Zhu, Hao, Wang, Chengniu, Zhao, Wei, Liu, Genxiang, Bao, Guofeng, Cui, Daoran, Fan, Jianbo, Wang, Fei, Jin, Huricha, Cui, Zhiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739656/ https://www.ncbi.nlm.nih.gov/pubmed/29285269 http://dx.doi.org/10.18632/oncotarget.22314 |
Ejemplares similares
-
Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget
por: Hatoum, Diana, et al.
Publicado: (2017) -
Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases
por: Bu, Yanhong, et al.
Publicado: (2021) -
The therapeutic value of the SphK1-targeting microRNA-3677 in human osteosarcoma cells
por: Yao, Chen, et al.
Publicado: (2020) -
Inhibition of SphK1 reduces radiation-induced migration and enhances sensitivity to cetuximab treatment by affecting the EGFR/SphK1 crosstalk
por: Schiefler, Carlotta, et al.
Publicado: (2014) -
Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation
por: Dai, Lan, et al.
Publicado: (2022)